SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " drug " 1,589 found 🔀 AI-powered Shuffle
Hims expansion may not come in time for risky GLP-1 business
Telehealth company Hims & Hers Health , known for its weight-loss drug business, is promising it can diversify away from its reliance on compounded GLP-1 sales in the U.S., but that may not happen soon enough for investors who are growing impatient.
Doing Science and Philosophy On Drugs
Doing Science and Philosophy On Drugs: Justin Smith-Ruiu takes a philosophical and first-person look at psychedelics
GLP-1s may increase risk of osteoporosis and gout, new research finds
A large analysis suggests the popular weight loss drugs may carry an increased risk to bone health.
BBC Audio | Business Daily | Weight-loss drugs. Who pays?
Weight-loss drugs have transformed lives but unleashed a debate about should pay for them
Wellness peptide craze: why people are injecting drugs 'not for human consumption'
Growing numbers of people are injecting unregulated peptides for health reasons - but one expert says they are "lab rats".
The WHO Chief Thinks Trump Is Missing a Political Opportunity
WHO’s Dr. Tedros combats vaccine skeptics, a $3,000 minipig powers Europe’s drug pipeline, and we appear to be entering our trillionaire era.
Saputo USA recalls Great Value cottage cheese due to possible health risk
Three types of Walmart Great Value brand cottage cheese products were voluntarily recalled by Saputo Cheese USA Inc. due to a possible health risk, the Food and Drug Administration announced Wednesday.
Scientists turn methane into medicine in stunning breakthrough
Scientists have unveiled a breakthrough way to turn natural gas—long burned as fuel—into valuable chemical building blocks for medicines and other high-demand products. By designing a clever iron-based catalyst powered by LED light, researchers managed to activate stubborn molecules like methane and transform them into complex compounds, even creating the hormone therapy drug dimestrol directly from methane for the first time.
Novo Nordisk to halve US list price of Wegovy from 2027
Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% starting next year to $675 a month, the Danish
Florida Department of Health cuts thousands of dollars in funds from HIV and AIDS drug program
Starting Sunday, the state will cut its subsidies for the AIDS Drug Assistance Program (ADAP), and funds will only be available for people at or below 130% of the federal poverty level, a drop from 400%.
RFK Jr. focuses on food as GOP fears midterm backlash to vaccine agenda
Health chief Robert F. Kennedy Jr. is on tour to tout his MAHA food initiatives and drug pricing over vaccines, an issue GOP pollsters see as a liability.
Berrien Co. health officials warn about 'gas station heroin' as state considers ban
The Berrien County Health Department is issuing a warning about a highly addictive drug, sometimes known as "gas station herion."It is readily available right n
How Leptin Became the Sexiest Thing in Science (Again)
Thirty years after its discovery, scientists are eyeing leptin with renewed interest, for everything from weight loss drug cocktails to novel treatments for rare diseases and anorexia.
This Looming Drug Development Gap Could Impact Patients' Health
In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
Breaking down the health care talk in Trump's State of the Union
Trump touts lower drug costs, states sue HHS, and other can't miss health news of the day
Dems plot health oversight blitz if they win midterms
Two top targets are the administration's drug pricing deals and its moves to limit vaccine recommendations.
Trump touts lower drug costs and anti-fraud measures in lengthy State of the Union
At SOTU, Trump touted health care wins even as more than half of Americans say health care has become more unaffordable for them and their families.
Michigan House committee hears testimony alleging mold, drugs, lack of health care at women’s prison
Lawmakers heard alarming testimony Tuesday detailing years of alleged neglect, toxic mold, illegal drugs, and inadequate health care at Michigan’s only women’s prison, prompting calls for oversight and policy changes.
Healthy Returns: What’s next for Novo Nordisk’s next-generation obesity drug CagriSema after trial miss
The Danish drugmaker released late-stage data showing that the upcoming injection CagriSema failed to match the weight loss of Eli Lilly’s Zepbound.
Digital twins, the holy grail of preventative health, are still only a ‘Frankensteinian proof of principle’
AI advances and new data on genomics, patient outcomes, and drug performance have pushed the idea of “digital twins” closer to reality than ever before.
A cartel crackdown carries political risks for Trump
President Donald Trump had put Mexico on notice: Go after the country’s powerful drug lords, or he would.
Merck to create separate cancer business to offset Keytruda patent loss, WSJ reports
Drugmaker Merck is separating its human-health business into two divisions to offset pressures related to the patent loss of its top-selling drug Keytruda, the Wall Street Journal reported on Monday.
Exclusive | Merck Creates Separate Cancer Business as Sales Pressure Looms
The drugmaker is splitting its pharmaceuticals unit to bolster product launches before a crucial patent loss.
PBM reforms promise relief for NC’s independent pharmacies
Federal and state actions seek transparency and fair reimbursements from pharmacy benefit managers, as rural communities lose local drugstores.
Zimbabwe rolls out long-acting HIV drug, among first countries to do so
Zimbabwe, where HIV has led to tens of thousands of deaths over the past two decades, is one of the first countries to roll out lenacapavir, a long-acting drug that authorities hope will slow new infections.
Simple blood test can forecast Alzheimer’s years before memory loss
Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to four years. The protein mirrors the silent buildup of amyloid and tau in the brain long before memory loss appears. This advance could speed up preventive drug trials and eventually guide personalized care.
Scientists discover why high altitude protects against diabetes
Living at high altitude appears to protect against diabetes, and scientists have finally discovered the reason. When oxygen levels drop, red blood cells switch into a new metabolic mode and absorb large amounts of glucose from the blood. This helps the body cope with thin air while also reducing blood sugar levels. A drug that recreates this effect reversed diabetes in mice, hinting at a powerful new treatment strategy.
US strikes alleged drug boat in eastern Pacific, killing 3
The US military conducted a strike against another alleged drug-trafficking boat in the eastern Pacific Ocean on Friday, killing three people, according to US Southern Command.
Would you trust AI to renew your drug prescriptions?
Would you trust AI to renew your drug prescriptions? Alex Hogan explores the question on this week's episode of STATus Report.
Replacing animals in science: what the UK’s new strategy means
Find out how the UK is leading the way in replacing animals in science with strategies that promote non-animal research methods.
Why have Americans turned against this lifesaving medication?
Statin hysteria has made it hard to convince people that this effective drug is actually very safe.
Scientists discover the body’s hidden “off switch” for inflammation
A new human study has uncovered how the body naturally turns off inflammation. Researchers found that fat-derived molecules called epoxy-oxylipins rein in immune cells that can otherwise drive chronic disease. Using a drug to boost these molecules reduced pain faster and lowered harmful inflammatory cells. The discovery could pave the way for safer treatments for arthritis, heart disease, and other inflammation-related conditions.
Chairman of Senate health committee floats an overhaul of FDA in new report
Sen. Bill Cassidy, R-La., has proposed ways to modernize the Food and Drug Administration in a new report. “While many parts of FDA work well, unnecessary bottlenecks slow patients and consumers ge…
Robert Pattinson says a therapist once asked him if he was on drugs because they 'couldn't understand' him
Robert Pattinson recalls that a therapist once thought he was on drugs, because they couldn't understand what he was saying.
Breakthrough CRISPR system could reverse antibiotic resistance crisis
Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR-based tool that doesn’t just fight resistant bacteria—it can actively strip away their drug resistance. Inspired by gene drives used in insects, the technology spreads a genetic “fix” through bacterial populations, even inside stubborn biofilms that shield microbes from antibiotics.
Taking Magnesium? Avoid These 5 Drugs and Other Supplements, Expert Says
Magnesium is an increasingly popular supplement to help with sleep and more. Here's how to take it as effectively as possible.
General Mills Wants to Win Health-Conscious Shoppers; Cut in Outlook Slams Stock
General Mills is getting aboard the GLP-1 train as the company navigates shaky consumer sentiment. Chief Executive Jeff Harmening told investors Tuesday that the weight-loss drugs will have a lasting influence on the business of food, nudging some consumers toward smaller portions, and more nutrien
Science, serendipity and a new era for schizophrenia treatment
Drug treatments for schizophrenia have barely changed in 70 years, but a mix of chance and ingenuity offers fresh hope
Scientists discover brain switches that clear Alzheimer’s plaques
Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s disease. By stimulating these receptors in mice, scientists increased levels of a natural amyloid-breaking enzyme, reduced buildup in the brain, and improved memory-related behavior. Because these receptors are common drug targets, the findings could open the door to affordable pill-based treatments with fewer side effects.
5 Questions to Ask Your Pharmacist at Your Next Visit
When you’re prescribed a medication, it’s important to understand why you’re taking the drug and how to take it. Learn what you should ask your pharmacist.
Should Drug Companies Be Advertising to Consumers?
Aging means “becoming a target” of the industry, one expert said. After decades of debate, politicians of all stripes are proposing bans.
Generative AI Revolutionizes the Life Sciences Industry Accelerating Drug Discovery, Cutting Costs, and Enhancing Innovation
According to data published by Precedence Research, Generative AI is transforming the life science sector, driving innovation in drug discovery, clinical trials, and manufacturing, while reducing costs and improving efficiency. With investments in AI, companies are reshaping R&D and achieving faster, smarter, and more personalized healthcare solutions.Ottawa, Feb. 16, 2026 (GLOBE NEWSWIRE) -- As Generative AI moves beyond pilot projects to become a foundational tool in the life sciences, it acce
She moved to France and her $36,000 asthma drug dropped to $3,000
High medical bills, safer systems, and better quality of life are driving a growing wave of health-motivated expats.
Health regulators to review safety of processed ingredients, RFK Jr. says
The Food and Drug Administration will consider a petition to revoke The safety status of dozens of processed refined carbohydrates unless food companies can prove they are safe.
US health regulators to consider safety status of processed ingredients, RFK Jr. says
The Food and Drug Administration will consider a petition to revoke the safety status of dozens of processed refined carbohydrates unless food companies can prove they are safe and not contributing to health issues and obesity, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said in remarks that aired on Sunday.
US Health Regulators to Consider Safety Status of Processed Ingredients, RFK Jr. Says
By Michelle Conlin NEW YORK, Feb 15 (Reuters) - The Food and Drug Administration will consider a petition to revoke the safety status of dozens of processed refined carbohydrates unless food companies can prove they are safe and not contributing to health issues and obesity, U.S. Health and ...
Kennedy Promises Action, Though Not Regulation, on Ultraprocessed Foods
The health secretary said the Food and Drug Administration would “act on” a request from a former F.D.A. commissioner to close a loophole on food safety.
Baby food recalled for ‘possible health risk’ in dozens of states, including Ohio
Some baby food products that were distributed across the country are being recalled for a potential health risk, the U.S. Food and Drug Administration announced.
Former Miami-Dade Democratic Party official arrested on drug possession charges at port
Ricardo 'Ricky' Junquera was one of nine people arrested Feb. 1 as they were about to depart on a cruise ship.
Assessing Suzhou Ribo Life Science’s Valuation After Recent Share Price Weakness
Recent share performance and business profile Suzhou Ribo Life Science (SEHK:6938) has drawn attention after a 5.4% one day decline to HK$70.05, extending a one month return of a 7.9% decline and a year to date return of a 14.7% decline. For context, the company focuses on researching and developing small nucleic acid drugs targeting cardiovascular, metabolic, renal, liver and other diseases, with several candidates in Phase I, Phase II and preclinical trials. See our latest analysis for...
It's a dangerous complication of pregnancy -- but a new drug holds promise
Researchers celebrate early results of a drug that may become the first treatment for a serious complication of pregnancy called preeclampsia. It's got the potential to save many lives.
Business on Harry Hines shut down in multi-agency enforcement operation
This comes roughly 10 days after officials announced the expansion of Project Safe Neighborhoods to battle violent crime, drug trafficking and human...
Federal raid shuts down Harry Hines adult bookstore
Federal agents halted operations at an adult bookstore as part of a probe into drug and prostitution activities in Dallas.
Major shakeup underway at HHS as White House braces for midterms
Several senior officials are exiting RFK Jr.'s department amid an effort to focus on drug pricing and food issues.
SF: Department Of Public Health Tries New Approaches As City's Overdose Deaths Jump In New Year
The San Francisco Department of Public Health is trying out new strategies to tackle the city's drug crisis after seeing a considerable jump in overdose deaths in January compared to the previous...
Can TrumpRx help you save money on drugs? Here's what experts say.
Bayer and celebrity chef keep diners in the dark to shed light on heart health
Bayer has cooked up the next phase of its “See Your Risks” campaign, tapping Food Network star Jeff Mauro as its sous chef. | Bayer has cooked up the next phase of its “See Your Risks” campaign with celebrity chef Jeff Mauro. The drugmaker is offering people the chance to dine in Mauro’s immersive dark dining experience, the Heart to Heart Bistro—provided they complete its aspirin heart health risk assessment.
Health chief Kennedy says he’s no germaphobe, recalls snorting cocaine off toilet seats
The Kennedy scion divulged his old drug habits on comedian Theo Von’s podcast “This Past Weekend.
Scientists create glowing wax moths to study infections
Engineered wax moth larvae may become a fast, low-cost way to study infections and screen new drugs before testing in mammals.
A good place to start Trump’s new health care plan: More drugs over the counter
The FDA should make more safe drugs available for over-the-counter purchase, starting with albuterol, in order to reduce costs and increase access to medicine.
Senate Questions Health Care Firm for Profiting Off Program Meant for Poor
The program was meant to help hospitals provide for poor patients by offering drug savings. But critics say a Texas company has turned it into a big business, driving up costs for patients and insurers.
Are Antidepressants Safe During Pregnancy?
Confusion about the safety of taking the drugs during pregnancy has led to mental health emergencies for some expectant mothers, experts say.
Health officials detect 'rhino tranq' in illegal drugs around Southern Nevada
Health officials say they’ve detected a powerful sedative in Southern Nevada's illicit drug supply.
Health Subcommittee Examines Prescription Drug Supply Chain to Lower Costs for American Patients
The Committee on Energy and Commerce is the oldest standing legislative committee in the U.S. House of Representatives and is vested with the broadest jurisdiction of any congressional authorizing committee.
Chairman Griffith Delivers Opening Statement at Subcommittee on Health Hearing Inviting Representatives of Our Prescription Drug Supply Chain
The Committee on Energy and Commerce is the oldest standing legislative committee in the U.S. House of Representatives and is vested with the broadest jurisdiction of any congressional authorizing committee.
Chairman Griffith Delivers Opening Statement at Subcommittee on Health Hearing Inviting Representatives of Our Prescription Drug Supply Chain
The Committee on Energy and Commerce is the oldest standing legislative committee in the U.S. House of Representatives and is vested with the broadest jurisdiction of any congressional authorizing committee.
FDA declines to review Moderna's mRNA flu shot
Under Health Secretary Robert F. Kennedy Jr., the Food and Drug Administration has taken an aggressive stance against mRNA technology.
Some health care CEOs are praising TrumpRx for empowering consumers to compare drug prices
Also: All the news and watercooler chat from Fortune.
Devex: Where is HIV prevention drug lenacapavir in ‘America First’ health deals?
Omitting HIV prevention targets from these deals will be devastating to the affordability and scale-up of lenacapavir. African leaders can change that.
New drug resets the body clock and cuts jet lag recovery nearly in half
Scientists have identified a promising new compound, Mic-628, that can reliably shift the body’s internal clock forward—something that’s notoriously hard to do. By targeting a key clock-control protein, Mic-628 jump-starts the gene that sets daily rhythms, synchronizing both the brain’s master clock and clocks throughout the body. In mice experiencing simulated jet lag, a single dose cut recovery time nearly in half.
Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.
Hims & Hers to stop offering compounded semaglutide pill after FDA crackdown
Hims & Hers said in a statement on Saturday that it will stop offering access to the compounded semaglutide pill after the U.S. Food and Drug Administration said it would take action against the telehealth provider for its $49 weight-loss pill.
Light-based Ising computer runs at room temperature and stays stable for hours
A team of researchers at Queen's University has developed a powerful new kind of computing machine that uses light to take on complex problems such as protein folding (for drug discovery) and number partitioning ...
Health Agency Refers Knockoff GLP-1 Provider Hims & Hers to Justice Department
The FDA said it would take “decisive steps” to restrict nonapproved drugs that use GLP-1 active pharmaceutical ingredients.
Mary Mayhew fears Washington push to simplify policy could starve Florida's hospitals
The former AHCA Secretary says site neutral payments and cuts to charity drug programs will hurt some already struggling hospitals.
Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data
Pfizer made one thing clear this week: It's officially back in the obesity race.
Headwinds in GoodRx’s (GDRX) Drug Prescription Business Draw Cautious View from Jefferies
GoodRx Holdings Inc. (NASDAQ:GDRX) is one of the best stocks under $3 to invest in, although one firm had recently become neutral on the stock. On January 22, analysts at Jefferies lowered their rating on GoodRx Holdings Inc. (NASDAQ:GDRX) to Hold from Buy and cut the price target to $2.75 from $5.25. According to Jefferies, […]
TrumpRx, the President’s Online Drugstore, Opens for Business
TrumpRx is aimed at helping patients use their own money to buy medicines. But researchers who study drug pricing warned that many patients could pay too much if they use the site.
New recall includes nearly 23K bottles of triglycerides drug used to treat heart disease
New Jersey-based Zydus Pharmaceuticals has recalled nearly 23,000 bottles of its icosapent ethyl capsules due to leakage issues that may have weakened their effectiveness.
Trump to launch TrumpRx.gov, branding his push to lower prescription prices
The president has argued his drug-pricing initiative ‘should win us the midterms.’ Experts say its impact could be positive but limited.
Health body issues warning over 'increased harm' from new drugs
The two alerts concern sedative drug medetomidine and new variants of another sedative, benzodiazepines.
340B is a Solution, not a Threat to Addressing Health Care Affordability in the U.S.
Many Americans may be unaware that the services they rely on every day through their local hospital are supported by a program called the 340B Drug Pricing Program.
Blood thinners are a leading cause of drug-related harm. Can the risk be lowered?
More than 8 million people in the U.S. take blood thinners to prevent dangerous clots. At the same time, the drugs are responsible for a staggering number of serious bleeding events.
Wegovy maker Novo Nordisk appoints Jamey Millar head of its US business
Danish drug maker Novo Nordisk said on Wednesday it had appointed Jamey Millar head of its U.S. business, and Hong Chow head of product and portfolio strategy.
‘Biblical Diseases’ Could Resurge in Africa, Health Officials Fear
Parasites and infections that cause blindness and other disabilities were nearly eliminated in some countries, but drug distribution to prevent and treat them was derailed in many places in 2025 after the U.S. cut aid.
The New Science of Craving
We often view our cravings—whether for drugs, alcohol, food, or approval—as indictments of our character. Yet neuroscience and psychology say otherwise; here's why.
PBMs hit by Trump transparency rule
Drug supply chain middlemen would have to disclose financial dealings with drugmakers, pharmacies and others.
The Wonder Drug That’s Plaguing Sports
Ostarine held the promise of profound medical treatments. Something unexpected happened on the way to F.D.A. approval.
Free HIV drugs save lives. Why one state is restricting access for thousands.
An estimated 16,000 HIV and AIDS patients in Florida might lose free medication, health care as the state dramatically rolls back a decades-old program.
Arctic Vision Announces Deal to Integrate MDCO Technology’s Ophthalmic Device Business to Form a Global Drug–Device Innovation Platform
SHANGHAI, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Headquartered in Shanghai, Arctic Vision (Cayman) Limited (“Arctic Vision”), a global ophthalmic company, announced that it has entered into an agreement to acquire the innovative ophthalmic device business of MDCO Technology, a Hangzhou-based ophthalmic medical-device company. The proposed transaction will bring MDCO’s premium intraocular lens (IOL), implantable contact lens (Phakic Lens), and refractive-device platforms into Arctic Vision’s global op
‘I’ve never taken drugs or drunk alcohol,’ says Zack Polanski
Green party leader wants to legalise all drugs, regulate their use and not be ‘the fun police’
Scientists discover how to turn gut bacteria into anti-aging factories
Researchers found that small doses of an antibiotic can coax gut bacteria into producing a life-extending compound. In worms, this led to longer lifespans, while mice showed healthier cholesterol and insulin changes. Because the drug stays in the gut, it avoids toxic side effects. The study points to a new way of promoting health by targeting microbes rather than the body itself.
Florida healthcare advocates protest cuts to state's AIDS Drug Assistance Program
Outside the Department of Health in St. Pete and Orlando Friday, healthcare advocates and the AIDS Healthcare Foundation (AHF) protested the proposed cuts to Florida’s AIDS Drug Assistance Program (ADAP).
New triple-drug treatment stops pancreatic cancer in its tracks, a mouse study finds
By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and prevented the cancer from returning, a promising step toward overcoming treatment resistance.
Designing the future of metabolic health through tissue-selective drug delivery
Founded by MIT alumni, the biotech firm Gensaic develops protein carriers that can deliver therapeutic molecules to specific tissues and cells.
Tanzania eyes East Africa’s pharmaceutical hub crown {Business Africa}
Tanzania is betting on local drug manufacturing to reduce imports and become East Africa’s pharmaceutical hub and we find out how Africa's private sector is fixing the supply chain to minimise the billions lost in post-harvest logistics.View on euronews
Science, Innovation, and the National Institutes of Health
Failing to support independent agency science imperils the uptake of innovative drugs.
Abortion Pill Safety Decisions by FDA Were Science-Based, New JAMA Study Finds — The Monitor
A new study found the FDA’s abortion pill decisions followed scientific evidence, as misleading claims about the drug’s safety continue to shape public understanding. And Google removed some health AI summaries after a Guardian investigation reported that AI-generated summaries contained false and potentially dangerous health information.
How Oprah Winfrey has turned her weight-loss journey into a business
Oprah Winfrey's newest book, "Enough," is about her relationship with weight-loss drugs. Since the '90s, she has been combining her health with business.